Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract LB-65: Advocating for Cancer Patients

View through CrossRef
Abstract The Lymphoma Foundation of America (LFA) is a national, nonprofit charity dedicated to helping cancer patients and their families. The organization provides support and counseling services, research, grants, a patient hotline, referrals, second opinions, information about patients' rights, and financial assistance to low-income families. LFA in comprised of a scientific panel of experts with backgrounds in epidemiology, genetic, and biomedical research. Peer-reviewed research reports are published by the Foundation. LFA's report entitled, “Do Pesticides Cause Lymphoma”, is a meta-analysis of the scientific literature on the association between pesticide exposures and nonhodgkin lymphoma. “Lymphoma and Solvents” is another well-known LFA-published report on the relationship between benzene and lymphoma. Each year, LFA selects promising, young university-based researchers for their outstanding work in cancer epidemiology to receive the “Young Scientist Award”. As part of the Foundation's education and outreach, it produces webcasts and partners with Patient Power to broadcast radio talk shows. These resources help patients gain the information needed to make appropriate decisions about their treatment options. The Foundation also takes an active role in national health policy. LFA served as the lead amicus organization in the Agent Orange case argued before the U.S. Supreme Court. Lymphoma Foundation of America also filed a precedent-setting Freedom of Information Act request with the National Cancer Institute (NCI). This FOIA request established the right of cancer patients to receive copies of their experimental treatment protocols in all federally-funded cancer clinical trials. LFA has testified at multiple congressional hearings on the environmental causes of cancer. Lymphoma Foundation of America is an independent nonprofit organization and does not accept drug company or medical industry funding. LFA is entirely supported by individuals and charitable foundations. The Lymphoma Foundation of America was founded in 1986 by lymphoma patients who came together to help each other recover from cancer. Today, LFA serves as a leading voice for the lymphoma patient community. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-65. doi:10.1158/1538-7445.AM2011-LB-65
American Association for Cancer Research (AACR)
Title: Abstract LB-65: Advocating for Cancer Patients
Description:
Abstract The Lymphoma Foundation of America (LFA) is a national, nonprofit charity dedicated to helping cancer patients and their families.
The organization provides support and counseling services, research, grants, a patient hotline, referrals, second opinions, information about patients' rights, and financial assistance to low-income families.
LFA in comprised of a scientific panel of experts with backgrounds in epidemiology, genetic, and biomedical research.
Peer-reviewed research reports are published by the Foundation.
LFA's report entitled, “Do Pesticides Cause Lymphoma”, is a meta-analysis of the scientific literature on the association between pesticide exposures and nonhodgkin lymphoma.
“Lymphoma and Solvents” is another well-known LFA-published report on the relationship between benzene and lymphoma.
Each year, LFA selects promising, young university-based researchers for their outstanding work in cancer epidemiology to receive the “Young Scientist Award”.
As part of the Foundation's education and outreach, it produces webcasts and partners with Patient Power to broadcast radio talk shows.
These resources help patients gain the information needed to make appropriate decisions about their treatment options.
The Foundation also takes an active role in national health policy.
LFA served as the lead amicus organization in the Agent Orange case argued before the U.
S.
Supreme Court.
Lymphoma Foundation of America also filed a precedent-setting Freedom of Information Act request with the National Cancer Institute (NCI).
This FOIA request established the right of cancer patients to receive copies of their experimental treatment protocols in all federally-funded cancer clinical trials.
LFA has testified at multiple congressional hearings on the environmental causes of cancer.
Lymphoma Foundation of America is an independent nonprofit organization and does not accept drug company or medical industry funding.
LFA is entirely supported by individuals and charitable foundations.
The Lymphoma Foundation of America was founded in 1986 by lymphoma patients who came together to help each other recover from cancer.
Today, LFA serves as a leading voice for the lymphoma patient community.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL.
Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-65.
doi:10.
1158/1538-7445.
AM2011-LB-65.

Related Results

Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...

Back to Top